Periconceptional GLP-1RA exposure safety varies on indication for use
11 Aug 2025
byJairia Dela Cruz
Exposure to glucagon-like peptide 1 receptor agonists (GLP-1RAs) during pregnancy poses a modest increase in the risk of preterm birth in the context of diabetes treatment, but there is no evidence of increased obstetric complications when the drugs are exclusively used for weight management, according to new research.
